Tilray Brands, Inc. (TLRY)
USD 0.46
(-21.23%)
USD 0.46
(-21.23%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 252.08 Million USD | 25.7% |
| 2023 | 200.55 Million USD | -18.32% |
| 2022 | 245.52 Million USD | -4.25% |
| 2021 | 256.42 Million USD | 34.57% |
| 2020 | 190.56 Million CAD | 181.69% |
| 2019 | 67.64 Million CAD | 293.82% |
| 2018 | 17.17 Million CAD | 495.41% |
| 2017 | 2.88 Million CAD | 80.14% |
| 2016 | 1.6 Million CAD | 15.44% |
| 2015 | 1.38 Million CAD | 2405590138.92% |
| 2014 | -0.06 CAD | 61.73% |
| 2013 | -0.15 CAD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 252.7 Million USD | 8.89% |
| 2024 FY | 252.08 Million USD | 25.7% |
| 2024 Q4 | 252.08 Million USD | 3.26% |
| 2024 Q1 | 232.07 Million USD | 15.72% |
| 2024 Q3 | 244.13 Million USD | -3.39% |
| 2023 Q3 | 202.8 Million USD | -15.83% |
| 2023 Q1 | 244.65 Million USD | -0.36% |
| 2023 Q2 | 240.94 Million USD | -1.52% |
| 2023 Q4 | 200.55 Million USD | -1.11% |
| 2023 FY | 200.55 Million USD | -18.32% |
| 2022 Q2 | 233.02 Million USD | -7.35% |
| 2022 Q4 | 245.52 Million USD | -10.16% |
| 2022 FY | 245.52 Million USD | -4.25% |
| 2022 Q1 | 251.5 Million USD | -1.92% |
| 2022 Q3 | 273.29 Million USD | 17.28% |
| 2021 Q2 | 269.89 Million CAD | 2.73% |
| 2021 Q1 | 262.71 Million CAD | 37.86% |
| 2021 Q3 | 267.5 Million CAD | -0.89% |
| 2021 FY | 256.42 Million USD | 34.57% |
| 2021 Q4 | 256.42 Million USD | -4.14% |
| 2020 Q2 | 114.52 Million CAD | 35.48% |
| 2020 Q3 | 168.56 Million CAD | 47.19% |
| 2020 Q4 | 190.56 Million CAD | 13.05% |
| 2020 Q1 | 84.53 Million CAD | 24.96% |
| 2020 FY | 190.56 Million CAD | 181.69% |
| 2019 Q4 | 67.64 Million CAD | 3.14% |
| 2019 FY | 67.64 Million CAD | 293.82% |
| 2019 Q2 | 30.38 Million CAD | 13.55% |
| 2019 Q3 | 65.58 Million CAD | 115.87% |
| 2019 Q1 | 26.75 Million CAD | 55.77% |
| 2018 FY | 17.17 Million CAD | 495.41% |
| 2018 Q3 | 9.2 Million CAD | 36.09% |
| 2018 Q4 | 17.17 Million CAD | 86.58% |
| 2018 Q2 | 6.76 Million CAD | 43.08% |
| 2018 Q1 | 4.72 Million CAD | 63.89% |
| 2017 Q3 | 2.01 Million CAD | -5.96% |
| 2017 Q1 | 2.08 Million CAD | 30.2% |
| 2017 Q2 | 2.14 Million CAD | 2.64% |
| 2017 Q4 | 2.88 Million CAD | 43.35% |
| 2017 FY | 2.88 Million CAD | 80.14% |
| 2016 Q1 | 1.55 Million CAD | 11.96% |
| 2016 Q2 | 1.51 Million CAD | -2.65% |
| 2016 Q4 | 1.6 Million CAD | 18.67% |
| 2016 FY | 1.6 Million CAD | 15.44% |
| 2016 Q3 | 1.34 Million CAD | -10.75% |
| 2015 Q3 | 721.28 Thousand CAD | 0.0% |
| 2015 Q2 | - CAD | 0.0% |
| 2015 Q1 | - CAD | 0.0% |
| 2015 FY | 1.38 Million CAD | 2405590138.92% |
| 2015 Q4 | 1.38 Million CAD | 92.35% |
| 2014 Q4 | - CAD | 0.0% |
| 2014 Q3 | - CAD | 0.0% |
| 2014 Q2 | - CAD | 0.0% |
| 2014 Q1 | - CAD | 0.0% |
| 2014 FY | - CAD | 61.73% |
| 2013 Q1 | - CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Journey Medical Corporation | 10.2 Million USD | -2369.988% |
| ANI Pharmaceuticals, Inc. | 111.19 Million USD | -126.705% |
| Aquestive Therapeutics, Inc. | 6.76 Million USD | -3624.139% |
| Pacira BioSciences, Inc. | 104.35 Million USD | -141.571% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | -4295.776% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | -4295.776% |
| SCYNEXIS, Inc. | - USD | -Infinity% |
| Safety Shot Inc | 1.86 Million USD | -13383.133% |
| Alpha Teknova, Inc. | 11.59 Million USD | -2074.288% |
| Collegium Pharmaceutical, Inc. | 32.33 Million USD | -679.683% |
| Bright Green Corporation | - USD | -Infinity% |
| Dynavax Technologies Corporation | 53.29 Million USD | -373.047% |
| Esperion Therapeutics, Inc. | 65.62 Million USD | -284.144% |
| Cosmos Health Inc. | 4.78 Million USD | -5163.816% |
| PainReform Ltd. | - USD | -Infinity% |
| China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -31031.191% |
| Embecta Corp. | 152.1 Million USD | -65.738% |
| Intra-Cellular Therapies, Inc. | 11.64 Million USD | -2064.394% |
| Procaps Group, S.A. | 96.83 Million USD | -160.332% |
| Theratechnologies Inc. | 6.06 Million USD | -4055.737% |
| Harrow Health, Inc. | 10.86 Million USD | -2219.748% |
| Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | -9171.313% |
| Biofrontera Inc. | 10.9 Million USD | -2211.029% |
| DURECT Corporation | 2.21 Million USD | -11260.388% |
| Supernus Pharmaceuticals, Inc. | 77.4 Million USD | -225.66% |
| Cronos Group Inc. | 30.33 Million USD | -730.901% |
| OptiNose, Inc. | 8.05 Million USD | -3030.738% |
| Ironwood Pharmaceuticals, Inc. | 1.00 USD | -25208699900.0% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| RedHill Biopharma Ltd. | 5.69 Million USD | -4323.329% |
| Organogenesis Holdings Inc. | 28.25 Million USD | -792.249% |
| Guardion Health Sciences, Inc. | 2.67 Million USD | -9316.379% |
| Cumberland Pharmaceuticals Inc. | 4.6 Million USD | -5369.022% |
| Radius Health, Inc. | 278.64 Million USD | 9.53% |
| Universe Pharmaceuticals INC | 3.34 Million USD | -7440.142% |
| ProPhase Labs, Inc. | 3.84 Million USD | -6463.056% |
| Phibro Animal Health Corporation | 265.91 Million USD | 5.199% |
| Procaps Group S.A. | 96.83 Million USD | -160.332% |
| Alvotech | 74.43 Million USD | -238.676% |
| TherapeuticsMD, Inc. | - USD | -Infinity% |
| Viatris Inc. | 3.46 Billion USD | 92.735% |
| Rockwell Medical, Inc. | 5.87 Million USD | -4193.766% |
| Aytu BioPharma, Inc. | 12.63 Million USD | -1895.464% |
| SIGA Technologies, Inc. | 64.21 Million USD | -292.547% |
| Lifecore Biomedical, Inc. | 39.97 Million USD | -530.549% |
| Shineco, Inc. | 1.58 Million USD | -15769.25% |
| PetIQ, Inc. | 159.3 Million USD | -58.238% |
| Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 165102.16% |
| Incannex Healthcare Limited | -10.01 Million USD | 2617.094% |
| Neurocrine Biosciences, Inc. | 38.3 Million USD | -558.191% |
| Alimera Sciences, Inc. | 1.87 Million USD | -13316.019% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 37.68 Million USD | -568.914% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Petros Pharmaceuticals, Inc. | 1.61 Million USD | -15553.776% |
| Clever Leaves Holdings Inc. | 4.48 Million USD | -5523.176% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -99009.502% |
| Avadel Pharmaceuticals plc | 10.38 Million USD | -2328.584% |
| Hempacco Co., Inc. | 2.54 Million USD | -9814.427% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 74.43 Million USD | -238.676% |
| Eagle Pharmaceuticals, Inc. | 47.79 Million USD | -427.445% |
| Lantheus Holdings, Inc. | 64.02 Million USD | -293.708% |
| Currenc Group, Inc. | 732.91 Thousand USD | -34295.309% |
| Kamada Ltd. | 87.74 Million USD | -187.289% |
| Indivior PLC | 141.79 Million USD | -77.777% |
| Evoke Pharma, Inc. | 481.84 Thousand USD | -52217.574% |
| Flora Growth Corp. | 8.5 Million USD | -2862.941% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -99009.502% |
| Evolus, Inc. | 10.99 Million USD | -2192.117% |
| HUTCHMED (China) Limited | 50.25 Million USD | -401.586% |
| Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | -138.193% |
| Akanda Corp. | 1.28 Million USD | -19488.793% |